Eris Lifesciences [ERIS] vs Poly Medicure [POLYMED] Detailed Stock Comparison

Eris Lifesciences

NSE

Poly Medicure

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Eris Lifesciences wins in 13 metrics, Poly Medicure wins in 7 metrics, with 0 ties. Eris Lifesciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Eris Lifesciences	Poly Medicure	Better
P/E Ratio (TTM)	61.28	53.60	Poly Medicure
Price-to-Book Ratio	8.31	7.09	Poly Medicure
Debt-to-Equity Ratio	75.74	6.52	Poly Medicure
PEG Ratio	1.47	2.79	Eris Lifesciences
EV/EBITDA	24.67	39.81	Eris Lifesciences
Profit Margin (TTM)	13.17%	21.18%	Poly Medicure
Operating Margin (TTM)	26.73%	20.56%	Eris Lifesciences
EBITDA Margin (TTM)	26.73%	20.56%	Eris Lifesciences
Return on Equity	10.75%	12.24%	Poly Medicure
Return on Assets (TTM)	5.00%	10.60%	Poly Medicure
Free Cash Flow (TTM)	$9.10B	$-906.06M	Eris Lifesciences
Dividend Yield	0.41%	0.14%	Eris Lifesciences
1-Year Return	38.68%	-11.23%	Eris Lifesciences
Price-to-Sales Ratio (TTM)	8.09	11.43	Eris Lifesciences
Enterprise Value	$263.97B	$182.13B	Eris Lifesciences
EV/Revenue Ratio	8.99	10.79	Eris Lifesciences
Gross Profit Margin (TTM)	76.07%	68.45%	Eris Lifesciences
Revenue per Share (TTM)	$216	$168	Eris Lifesciences
Earnings per Share (Diluted)	$28.41	$35.52	Poly Medicure
Beta (Stock Volatility)	-0.03	0.04	Eris Lifesciences

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Eris Lifesciences vs Poly Medicure Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Eris Lifesciences	0.98%	3.98%	-0.96%	16.32%	36.93%	31.57%
Poly Medicure	5.39%	3.09%	-6.07%	-21.23%	-11.73%	-26.82%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Eris Lifesciences	38.68%	153.19%	238.28%	191.21%	191.21%	191.21%
Poly Medicure	-11.23%	159.08%	362.94%	871.42%	5,928.54%	5,928.54%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Eris Lifesciences (ERIS): View Full Stock Overview

Poly Medicure (POLYMED): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Eris Lifesciences vs Poly Medicure

Metric	ERIS	POLYMED
Market Information
Market Cap i	₹237.39B	₹192.89B
Market Cap Category	Large cap	Mid cap
10 Day Avg. Volume i	159,048	210,523
90 Day Avg. Volume i	117,654	146,883
Last Close	₹1,768.70	₹2,070.60
52 Week Range	₹1,097.20 - ₹1,910.00	₹1,821.20 - ₹3,357.80
% from 52W High	-7.40%	-38.33%
All-Time High	₹1,910.00 (Jun 09, 2025)	₹3,357.80 (Oct 28, 2024)
% from All-Time High	-7.40%	-38.33%
Growth Metrics
Quarterly Revenue Growth	0.08%	0.05%
Quarterly Earnings Growth	0.42%	0.26%
Financial Health
Profit Margin (TTM) i	0.13%	0.21%
Operating Margin (TTM) i	0.27%	0.21%
Return on Equity (TTM) i	0.11%	0.12%
Debt to Equity (MRQ) i	75.74	6.52
Cash & Liquidity
Book Value per Share (MRQ)	₹209.63	₹268.63
Cash per Share (MRQ)	₹15.09	₹119.26
Operating Cash Flow (TTM) i	₹7.57B	₹2.95B
Levered Free Cash Flow (TTM) i	₹3.52B	₹3.39B
Dividends
Last 12-Month Dividend Yield i	0.41%	0.14%
Last 12-Month Dividend i	₹7.35	₹3.00

Valuation & Enterprise Metrics Analysis: Eris Lifesciences vs Poly Medicure

Metric	ERIS	POLYMED
Price Ratios
P/E Ratio (TTM) i	61.28	53.60
Forward P/E i	41.80	247.88
PEG Ratio i	1.47	2.79
Price to Sales (TTM) i	8.09	11.43
Price to Book (MRQ) i	8.31	7.09
Market Capitalization
Market Capitalization i	₹237.39B	₹192.89B
Enterprise Value i	₹263.97B	₹182.13B
Enterprise Value Metrics
Enterprise to Revenue i	8.99	10.79
Enterprise to EBITDA i	24.67	39.81
Risk & Other Metrics
Beta i	-0.03	0.04
Book Value per Share (MRQ) i	₹209.63	₹268.63

Financial Statements Comparison: Eris Lifesciences vs Poly Medicure

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	ERIS	POLYMED
Revenue/Sales i	₹7.72B	₹4.03B
Cost of Goods Sold i	₹1.85B	₹1.27B
Gross Profit i	₹5.87B	₹2.76B
Research & Development i	N/A	₹66.81M
Operating Income (EBIT) i	₹2.06B	₹828.81M
EBITDA i	₹2.80B	₹1.49B
Pre-Tax Income i	₹1.61B	₹1.23B
Income Tax i	₹360.00M	₹298.63M
Net Income (Profit) i	₹1.25B	₹930.83M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	ERIS	POLYMED
Cash & Equivalents i	₹2.00B	₹86.99M
Total Current Assets i	₹12.23B	₹19.17B
Total Current Liabilities i	₹13.81B	₹3.70B
Long-Term Debt i	₹17.82B	₹7.71M
Total Shareholders Equity i	₹32.72B	₹27.66B
Retained Earnings i	₹27.93B	N/A
Property, Plant & Equipment i	₹2.36B	₹10.41B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	ERIS	POLYMED
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	ERIS	POLYMED
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	159,048	210,523
Average Daily Volume (90 Day) i	117,654	146,883
Shares Outstanding i	136.16M	101.33M
Float Shares i	40.85M	33.23M
% Held by Insiders i	0.69%	0.67%
% Held by Institutions i	0.21%	0.19%

Dividend Analysis & Yield Comparison: Eris Lifesciences vs Poly Medicure

Metric	ERIS	POLYMED
Last 12-Month Dividend i	₹7.35	₹3.00
Last 12-Month Dividend Yield i	0.41%	0.14%
3-Year Avg Annual Dividend i	₹4.90	₹2.83
3-Year Avg Dividend Yield i	0.82%	0.21%
3-Year Total Dividends i	₹14.70	₹8.50
Ex-Dividend Date	Feb 13, 2025	Sep 19, 2024

Eris Lifesciences [ERIS] vs Poly Medicure [POLYMED] Detailed Stock Comparison